Drug Description in Trials / DrugBank / KEGG DRUG


Search results


No. Drug (Description in trials) DrugBank KEGG DRUG KEGG GENES KEGG PATHWAY Disease ID
1Bydureon[1] Exenatide[1] Exenatide (BYDUREON BCISE) 💬 [1] GLP1R 💬 [4] Hormone signaling, Insulin secretion, Neuroactive ligand-receptor interaction, cAMP signaling pathway 💬[2] 6, 17 💬
2Bydureon 2 MG powder and solvent FOR prolonged-release suspension[1] Exenatide[1] Exenatide (BYDUREON BCISE) 💬 [1] GLP1R 💬 [4] Hormone signaling, Insulin secretion, Neuroactive ligand-receptor interaction, cAMP signaling pathway 💬[1] 6 💬
3Exenatide
(BYDUREON BCISE)
[1] Exenatide[1] Exenatide (BYDUREON BCISE) 💬 [1] GLP1R 💬 [4] Hormone signaling, Insulin secretion, Neuroactive ligand-receptor interaction, cAMP signaling pathway 💬[5] 6, 17, 78, 193, 233 💬
4Exenatide 10 micrograms
(BYDUREON BCISE)
[1] Exenatide[1] Exenatide (BYDUREON BCISE) 💬 [1] GLP1R 💬 [4] Hormone signaling, Insulin secretion, Neuroactive ligand-receptor interaction, cAMP signaling pathway 💬[1] 6 💬
5Exenatide 5 micrograms
(BYDUREON BCISE)
[1] Exenatide[1] Exenatide (BYDUREON BCISE) 💬 [1] GLP1R 💬 [4] Hormone signaling, Insulin secretion, Neuroactive ligand-receptor interaction, cAMP signaling pathway 💬[1] 6 💬
6GLP1-RA (exenatide) administration
(BYDUREON BCISE)
----[1] 78 💬